CORE MOLDING TECHNOLOGIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CORE MOLDING TECHNOLOGIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $56.12M | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | $74.66M | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | $81.25M | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | $72.27M | Mar 13, 2020 |
| FY2019 | Dec 31, 2018 | $73.16M | Mar 13, 2020 |
| FY2019 | Sep 30, 2018 | $64.68M | Mar 13, 2020 |
| FY2019 | Jun 30, 2018 | $68.60M | Mar 13, 2020 |
| FY2019 | Mar 31, 2018 | $63.05M | Mar 13, 2020 |
| FY2019 | Dec 31, 2017 | $39.07M | Mar 13, 2020 |
| FY2019 | Sep 30, 2017 | $38.49M | Mar 13, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.68M | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | $58.44M | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | $79.24M | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | $61.45M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $62.50M | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | $72.99M | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | $88.74M | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | $78.15M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $73.78M | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | $86.73M | Mar 10, 2026 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2017 | $39.07M | Mar 7, 2018 |
| FY2016 | Sep 30, 2017 | $38.49M | Mar 7, 2018 |
| FY2016 | Jun 30, 2017 | $47.37M | Mar 7, 2018 |
| FY2016 | Mar 31, 2017 | $36.75M | Mar 7, 2018 |
| FY2016 | Dec 31, 2016 | $49.07M | Mar 7, 2018 |
| FY2016 | Sep 30, 2016 | $41.34M | Mar 7, 2018 |
| FY2016 | Jun 30, 2016 | $39.01M | Mar 7, 2018 |
| FY2016 | Mar 31, 2016 | $45.47M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $46.56M | Mar 7, 2018 |
| FY2016 | Sep 30, 2015 | $48.05M | Mar 7, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.34M | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | $10.15M | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | $14.31M | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | $11.78M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $9.89M | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | $12.35M | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | $17.73M | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | $13.31M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $10.94M | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | $15.28M | Mar 10, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.08M | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | $1.88M | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | $4.05M | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | $2.18M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($39.0K) | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | $3.16M | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | $6.42M | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | $3.76M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $2.18M | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | $4.35M | Mar 10, 2026 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.59M | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | $2.57M | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | $5.21M | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | $2.84M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $869.0K | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | $3.61M | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | $7.49M | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | $4.73M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $2.52M | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | $5.88M | Mar 10, 2026 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.90M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.70M | Mar 10, 2026 |
| FY2023 | Dec 31, 2022 | $1.60M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $1.30M | Mar 12, 2024 |
| FY2021 | Dec 31, 2020 | $1.20M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $1.20M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $1.03M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $848.0K | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $965.0K | Mar 18, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.36M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $36.57M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $37.98M | Mar 10, 2026 |
| FY2023 | Dec 31, 2022 | $34.40M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $30.28M | Mar 12, 2024 |
| FY2021 | Dec 31, 2020 | $24.08M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $28.93M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $27.84M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $16.69M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $16.38M | Mar 18, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.19M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $35.15M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $34.84M | Mar 10, 2026 |
| FY2023 | Dec 31, 2022 | $18.98M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $12.55M | Mar 12, 2024 |
| FY2021 | Dec 31, 2020 | $28.16M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $16.70M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | ($6.53M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $6.91M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $26.07M | Mar 18, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.27M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $11.53M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $9.10M | Mar 10, 2026 |
| FY2023 | Dec 31, 2022 | $16.59M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $11.57M | Mar 12, 2024 |
| FY2021 | Dec 31, 2020 | $3.68M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $7.46M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $5.80M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $4.26M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $2.86M | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $228.13M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $209.55M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | $213.38M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $198.62M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | $186.69M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $165.51M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $179.31M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $201.20M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $138.58M | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | $133.46M | Mar 7, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.96M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $62.19M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | $74.42M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $82.49M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | $86.60M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $71.58M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $94.88M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $102.27M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $36.69M | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | $36.69M | Mar 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $158.17M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $147.36M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $138.95M | Mar 10, 2026 |
| FY2025 | Dec 31, 2022 | $116.13M | Mar 10, 2026 |
| FY2023 | Dec 31, 2021 | $100.10M | Mar 11, 2025 |
| FY2023 | Dec 31, 2020 | $93.93M | Mar 12, 2024 |
| FY2021 | Dec 31, 2019 | $84.43M | Mar 14, 2023 |
| FY2021 | Dec 31, 2018 | $98.93M | Mar 11, 2022 |
| FY2020 | Dec 31, 2017 | $102.96M | Mar 11, 2021 |
| FY2019 | Dec 31, 2016 | $96.77M | Mar 13, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.38M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $17.38M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $17.38M | Mar 10, 2026 |
| FY2023 | Dec 31, 2022 | $17.38M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $17.38M | Mar 12, 2024 |
| FY2021 | Dec 31, 2020 | $17.38M | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | $17.38M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $21.48M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $2.40M | Mar 13, 2020 |
| FY2016 | Dec 31, 2016 | $2.40M | Mar 7, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $146.56M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $135.37M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | $122.07M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $101.75M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | $89.54M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $84.87M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $76.71M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $91.93M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $96.43M | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | $91.92M | Mar 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.06M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $41.80M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | $24.10M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $4.18M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | $6.15M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $4.13M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.86M | Mar 11, 2021 |
| FY2020 | Dec 31, 2018 | $1.89M | Mar 11, 2021 |
| FY2020 | Dec 31, 2017 | $26.78M | Mar 11, 2021 |
| FY2019 | Dec 31, 2016 | $28.29M | Mar 13, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.64M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $19.71M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | $21.52M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $22.99M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | $21.25M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $25.20M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $37.78M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $3.75M | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | $9.75M | Mar 7, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Mar 10, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Mar 10, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.51M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 8.61M | Mar 10, 2026 |
| FY2023 | Dec 31, 2023 | 8.66M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 8.42M | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | 8.24M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | 7.98M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 7.88M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 7.78M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 7.71M | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | 7.64M | Mar 7, 2018 |